Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lund

Showing results (61-70 of 754) with videos related to

Pageof 76
Sort By:
Postgraduate Medicine|November 1, 1975
Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertensionP Lund-Johansen
Acta Medica Scandinavica. Supplementum|January 1, 1976
Hemodynamic trends in untreated essential hypertension. Preliminary report on a 10 year follow-up studyP Lund-Johansen
American Journal of Hypertension|July 1, 1993
Cardiac effects of isradipine in patients with hypertensionP Lund-Johansen
The American Journal of Medicine|October 17, 1983
Short- and long-term (six-year) hemodynamic effects of labetalol in essential hypertensionP Lund-Johansen
Hypertension (Dallas, Tex. : 1979)|September 1, 1983
Hemodynamic response: decrease in cardiac output vs reduction in vascular resistanceP Lund-Johansen
Acta Medica Scandinavica. Supplementum|January 1, 1981
The Norwegian Multicenter Study on timolol after myocardial infarction. Part II. Effect in different risk groups, causes of death, heart arrest, reinfarctions, rehospitalizations and adverse experiencesP Lund-Johansen
Scandinavian Journal of Social Medicine. Supplementum|January 1, 1982
Physical activity and hypertensionP Lund-Johansen
Blood Pressure. Supplement|January 1, 1992
Hemodynamics of elevated blood pressureP Lund-Johansen
Acta Medica Scandinavica. Supplementum|January 1, 1979
Hemodynamic long-term effects of labetalol in essential hypertensionP Lund-Johansen
Journal of Cardiovascular Pharmacology|January 1, 1991
Essential hypertension: hemodynamic and therapeutic changes over 20 yearsP Lund-Johansen
Pageof 76

Showing results (61-70 of 754) with videos related to

Sort By:
Pageof 76
Postgraduate Medicine|November 1, 1975
Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertensionP Lund-Johansen
Acta Medica Scandinavica. Supplementum|January 1, 1976
Hemodynamic trends in untreated essential hypertension. Preliminary report on a 10 year follow-up studyP Lund-Johansen
American Journal of Hypertension|July 1, 1993
Cardiac effects of isradipine in patients with hypertensionP Lund-Johansen
The American Journal of Medicine|October 17, 1983
Short- and long-term (six-year) hemodynamic effects of labetalol in essential hypertensionP Lund-Johansen
Hypertension (Dallas, Tex. : 1979)|September 1, 1983
Hemodynamic response: decrease in cardiac output vs reduction in vascular resistanceP Lund-Johansen
Acta Medica Scandinavica. Supplementum|January 1, 1981
The Norwegian Multicenter Study on timolol after myocardial infarction. Part II. Effect in different risk groups, causes of death, heart arrest, reinfarctions, rehospitalizations and adverse experiencesP Lund-Johansen
Scandinavian Journal of Social Medicine. Supplementum|January 1, 1982
Physical activity and hypertensionP Lund-Johansen
Blood Pressure. Supplement|January 1, 1992
Hemodynamics of elevated blood pressureP Lund-Johansen
Acta Medica Scandinavica. Supplementum|January 1, 1979
Hemodynamic long-term effects of labetalol in essential hypertensionP Lund-Johansen
Journal of Cardiovascular Pharmacology|January 1, 1991
Essential hypertension: hemodynamic and therapeutic changes over 20 yearsP Lund-Johansen
Pageof 76